Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | TXK | P42681 | 1/20 | 0.30 |
| ▸ | ITK | Q08881 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.30 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10038745 | 0.94 | PTGDR2 (0.30) | PTGDR2 | |
| SCHEMBL10069233 | 0.91 | CA1 (0.38) | ABCG2KMT2AMEN1NPC1CA1 | |
| SCHEMBL10069238 | 0.84 | PTGDR2 (0.34) | ABCG2KMT2AMEN1NPC1CA1 | |
| SCHEMBL10038725 | 0.82 | PTGDR2 (0.31) | PTGDR2 | |
| SCHEMBL10038743 | 0.82 | PTGDR2 (0.31) | PTGDR2 | |
| SCHEMBL126369 | 0.81 | CRHBP (0.33) | ABCG2KMT2AMEN1NPC1PTGDR2 | |
| SCHEMBL10038681 | 0.81 | CRHBP (0.32) | ABCG2KMT2AMEN1NPC1PTGDR2 | |
| SCHEMBL10038742 | 0.80 | CRHBP (0.31) | ABCG2KMT2AMEN1NPC1PTGDR2 | |
| SCHEMBL13720708 | 0.78 | TSHR (0.43) | ABCG2KMT2AMEN1NPC1PTGDR2 | |
| SCHEMBL10038771 | 0.77 | TSHR (0.35) | ABCG2KMT2AMEN1NPC1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160181527-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-23 | — | — | US | disclosed |
| US-9331285-B2 | Aromatic amine derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20120013244-A1 | ORGANIC LUMINESCENT MEDIUM | IDEMITSU KOSAN CO., LTD. | 2012-01-19 | — | — | US | disclosed |
| US-20110297923-A1 | Aromatic amine derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120013244-A1 | ORGANIC LUMINESCENT MEDIUM | ANXA1, ANXA11, GLB1 | ABCG2 77/4885KMT2A 4602/4885MEN1 284/4885 |
| US-20110297923-A1 | Aromatic amine derivative and organic electroluminescent element using same | H1-4, H1-2, H1-0 | ABCG2 3032/4885KMT2A 200/4885MEN1 883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.